Economic evaluation of a disease management program for chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 8, Issue 3, 2011, Pages 153-159

  Dewan, Naresh A ^a,b   Rice, Kathryn L ^c,d   Caldwell, Michael ^a   Hilleman, Daniel E ^e  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

Chronic Obstructive Pulmonary Disease; Disease Management; Economics; Education

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; STEROID;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE MANAGEMENT PROGRAM; ECONOMIC EVALUATION; EMERGENCY WARD; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

COST SAVINGS; COSTS AND COST ANALYSIS; DISEASE MANAGEMENT; EMERGENCY SERVICE, HOSPITAL; HEALTH CARE COSTS; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 79957611489     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.560129     Document Type: Article

References (18)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002; 51(6):1-16.
2. National Heart, Lung, and Blood Institute, National Institutes of Health. Morbidity and mortality: 2008 chart book on cardiovascular, lung, and blood diseases. http://www.nhlbi.nih.gov// resources/docs/04a chtbk.pdf. Accessed July 2009.
3. Britton M. The burden of COPD in the UK: results from the Confronting COPD survey. Respir Med 2003; 97 (Suppl C): S71-S79. (Pubitemid 36266872)
4. Hilleman DE, Dewan NA, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 2001; 118:1278-1285.
5. Hunter DJ, Fairfield G. Disease management. BMJ 1997; 315:50-53. (Pubitemid 27271690)
6. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupr'e A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, Singh R, Collet JP. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: A disease-specific self-management intervention. Arch Intern Med 2003; 163(5):585-591. (Pubitemid 36314346)
7. Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernandez C, AlonsoA, del Pozo F, de Toledo P, Anto' JM, Rodri'quez-RoisinR, Decramer M; members of the CHRONIC Project. Integrated care prevents hospitalizations for exacerbations in COPD patients. Eur Respir J 2006; 28(1):123-130. (Pubitemid 44914269)
8. Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J 2004; 34(11):608-614. (Pubitemid 39587142)
9. Farrero E, Escarrabill J, Prats E, et al. Impact of a hospital-based home-care program on themanagement of COPDpatients receiving long-term oxygen therapy. Chest 2001; 119(2):364-369. (Pubitemid 32163744)
10. Ofman JJ, Badamgarav E, Henning JM, et al. Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med 2004; 117:182-192. (Pubitemid 39055870)
11. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systemic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Int Med 2007; 167:551-561. (Pubitemid 46513224)
12. Gallefoss F, Bakke PS. Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD-a 1 year follow-up randomized, controlled trial. Respir Med 2002; 96:424-431. (Pubitemid 36443159)
13. Bourbeau J, Collet JP, Schwartzman K, Ducruet T, Nault D, Bradley C. Economic benefits of self-management education in COPD. Chest 2006; 130:1704-1711. (Pubitemid 46033422)
14. Steuten LMG, Lemmens KMM, Nieboer AP, Vrijhoef HJM. Identifying potentially cost effective chronic care programs for people with COPD. Int J COPD 2009; 4:87-100.
15. Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, Kumari S, Thomas M, Geist LJ, Beaner C, Caldwell M, Niewoehner DE. Disease management program for Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Am J. Respir Crit Care Med 2010; 182:890-896.
16. Lipscomb J, Yabroff KR, Brown ML, Lawrence W, Barnett PG. Health care costing: data, methods, current applications. Med Care 2009; 47 (suppl 7):S1-S6.
17. Taylor SJC, Candy B, Bryar RM, Ramsay J, Vrijhoef HJM, Esmond G,Wedzicha JA, Griffiths CJ. Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence. BMJ doi:10.1136/bmj.38512.664167.8F (published 10 August 2005).
18. Effing TW, Monninkhof EM, Van Der Valk PDLPM, Zielhuis GGA, Walters EH, Van Der Palen JJ, Zwerink M. Selfmanagement education for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2007 4. Art. No: CD002990. DOI:0.1002/14651858.CD002990. pub2.